195 related articles for article (PubMed ID: 20008977)
1. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
Seo Y; Aparici CM; Cooperberg MR; Konety BR; Hawkins RA
J Nucl Med; 2010 Jan; 51(1):31-6. PubMed ID: 20008977
[TBL] [Abstract][Full Text] [Related]
2. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
3. Progress in SPECT/CT imaging of prostate cancer.
Seo Y; Franc BL; Hawkins RA; Wong KH; Hasegawa BH
Technol Cancer Res Treat; 2006 Aug; 5(4):329-36. PubMed ID: 16866563
[TBL] [Abstract][Full Text] [Related]
4. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.
Hardie AD; Rieter WJ; Bradshaw ML; Gordon LL; Young MA; Keane TE
World J Urol; 2013 Dec; 31(6):1327-32. PubMed ID: 23595605
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
Ellis RJ; Kaminsky DA; Zhou EH; Fu P; Chen WD; Brelin A; Faulhaber PF; Bodner D
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):29-34. PubMed ID: 20961696
[TBL] [Abstract][Full Text] [Related]
7. Capromab Pendetide imaging of prostate cancer.
Haseman MK; Rosenthal SA; Polascik TJ
Cancer Biother Radiopharm; 2000 Apr; 15(2):131-40. PubMed ID: 10803318
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
Raj GV; Partin AW; Polascik TJ
Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
[TBL] [Abstract][Full Text] [Related]
9. 111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
Tsivian M; Wright T; Price M; Mouraviev V; Madden JF; Kimura M; Wong T; Polascik TJ
Urol Oncol; 2012; 30(2):150-4. PubMed ID: 20189846
[TBL] [Abstract][Full Text] [Related]
10. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD; Goodman MM
Radiology; 2011 Jun; 259(3):852-61. PubMed ID: 21493787
[TBL] [Abstract][Full Text] [Related]
11. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging.
Wong WW; Schild SE; Vora SA; Ezzell GA; Nguyen BD; Ram PC; Roarke MC
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e423-9. PubMed ID: 21477947
[TBL] [Abstract][Full Text] [Related]
12. Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.
Mouraviev V; Madden JF; Broadwater G; Mayes JM; Burchette JL; Schneider F; Smith J; Tsivian M; Wong T; Polascik TJ
J Urol; 2009 Sep; 182(3):938-47. PubMed ID: 19616259
[TBL] [Abstract][Full Text] [Related]
13. [Improvement of Standardized Uptake Value Accuracy in the
Nakamura Y; Kangai Y; Abe T; Nakahara Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2021; 77(9):921-931. PubMed ID: 34544916
[TBL] [Abstract][Full Text] [Related]
14. Using vascular structure for CT-SPECT registration in the pelvis.
Hamilton RJ; Blend MJ; Pelizzari CA; Milliken BD; Vijayakumar S
J Nucl Med; 1999 Feb; 40(2):347-51. PubMed ID: 10025845
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.
Rieter WJ; Keane TE; Ahlman MA; Ellis CT; Spicer KM; Gordon LL
Clin Nucl Med; 2011 Oct; 36(10):872-8. PubMed ID: 21892036
[TBL] [Abstract][Full Text] [Related]
16. Automatic estimation of detector radial position for contoured SPECT acquisition using CT images on a SPECT/CT system.
Liu RR; Erwin WD
Med Phys; 2006 Aug; 33(8):2800-8. PubMed ID: 16964856
[TBL] [Abstract][Full Text] [Related]
17. Image quantification for radiation dose calculations--limitations and uncertainties.
Pereira JM; Stabin MG; Lima FR; Guimarães MI; Forrester JW
Health Phys; 2010 Nov; 99(5):688-701. PubMed ID: 20938240
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
Nagda SN; Mohideen N; Lo SS; Khan U; Dillehay G; Wagner R; Campbell S; Flanigan R
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):834-40. PubMed ID: 17293236
[TBL] [Abstract][Full Text] [Related]
19. Update on fused capromab pendetide imaging of prostate cancer.
Sodee DB; Nelson AD; Faulhaber PF; Maclennan GT; Resnick MI; Bakale G
Clin Prostate Cancer; 2005 Mar; 3(4):230-8. PubMed ID: 15882479
[TBL] [Abstract][Full Text] [Related]
20. Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)--proof of concept and initial imaging results.
Franc BL; Cho SY; Rosenthal SA; Cui Y; Tsui B; Vandewalker KM; Holz AL; Poonamallee U; Pomper MG; James RB
Eur J Radiol; 2013 Nov; 82(11):1877-84. PubMed ID: 23993140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]